Journal issues > Issue 4, June 2025 > EMUC24 report: Highlights and key takeaways at the multidisciplinary congress

EMUC24 report: Highlights and key takeaways at the multidisciplinary congress

By: A. Merseburger MD, PhD, H. Van Popple MA, PhD, A. Stenzl MD, PhD, E. de Groot

SUMMARY

The 16th European Multidisciplinary Congress on Urological Cancers (EMUC24) served as a pivotal meeting point for the onco-urology community, highlighting the latest scientific discoveries and their potential to transform clinical practice. Topics such as novel therapeutic combinations, advances in molecular diagnostics, and real-world data from European studies took centre stage. This article provides some of the most relevant takeaways from the congress, emphasising their impact on daily practice, ongoing research efforts, and the future of personalised treatment.

(BELG J MED ONCOL 2025;19(4):185–189)

To read the full artice you have the following options:

Click here to log in. Register for a free subscription*

* (only possible for healthcare professionals with RIZIV/INAMI/MATRICULE working in the field of Oncology/Hemato-oncology in Belgium and Luxembourg with prescription authorisation)

Purchase this article for €3.03

** (for healthcare professionals with prescribing authorisation working outside the field of Oncology/Hemato-oncology in Belgium and Luxembourg as well as those without prescribing authorisation working as healthcare professional in Oncology/Hemato-oncology in Belgium and Luxembourg, plus persons without prescription authorisation working outside Belgium and Luxembourg, plus healthcare professionals with prescribing authorisation outside Belgium and Luxembourg plus non-healthcare professionals from outside or inside Belgium or Luxembourg)

Top